Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manuel Anguita

Showing results (181-190 of 266) with videos related to

Pageof 27
Sort By:
Revista Espanola De Cardiologia (English Ed.)|October 18, 2011
Differences in outcome of heart failure with preserved or depressed systolic function in patients older than 70 years who receive beta blockersManuel Anguita, Juan C Castillo, Martín Ruiz, et al.
Revista Espanola De Cardiologia (English Ed.)|September 22, 2016
Challenges in Oral Lipid-lowering Therapy: Position Document of the Spanish Society of CardiologyManuel Anguita Sánchez, Almudena Castro Conde, Alberto Cordero Fort, et al.
REC, Interventional Cardiology|May 29, 2025
Infectious endocarditis on percutaneous aortic valve prosthesis: comparison with surgical bioprosthesesLucas Barreiro, Álvaro Roldán, Nerea Aguayo, et al.
Journal of Geriatric Cardiology : JGC|August 26, 2024
Clinical profile and outcomes in very elderly patients with atrial fibrillation anticoagulated with rivaroxaban: data from the EMIR studyFrancisco Marín, Manuel Anguita Sánchez, Iñaki Lekuona, et al.
European Journal of Internal Medicine|April 19, 2020
Influence of sex on long-term prognosis in patients with atrial fibrillation treated with oral anticoagulants. Results from the prospective, nationwide FANTASIIA studyInmaculada Roldán Rabadán, María Asunción Esteve-Pastor, Manuel Anguita Sánchez, et al.
Journal of the American Heart Association|December 25, 2019
Association of Body Mass Index With Clinical Outcomes in Patients With Atrial Fibrillation: A Report From the FANTASIIA RegistryVicente Bertomeu-Gonzalez, José Moreno-Arribas, María Asunción Esteve-Pastor, et al.
Journal of Clinical Medicine|January 8, 2025
No Obesity Paradox for Health-Related Quality of Life in Patients with Heart Failure and Reduced Ejection Fraction: Insights from the VIDA Multicenter StudyPaula Cassadó-Valls, Cristina Enjuanes, Manuel Anguita, et al.
Revista Espanola De Cardiologia (English Ed.)|August 31, 2016
Classification and Quality Standards of Heart Failure Units: Scientific Consensus of the Spanish Society of CardiologyManuel Anguita Sánchez, José Luis Lambert Rodríguez, Ramón Bover Freire, et al.
Expert Opinion on Pharmacotherapy|August 4, 2022
A comparison of front-line oral anticoagulants for the treatment of non-valvular atrial fibrillation: effectiveness and safety of direct oral anticoagulants in the FANTASIIA registryMaría Asunción Esteve-Pastor, José Miguel Rivera-Caravaca, Martín Ruiz-Ortiz, et al.
European Journal of Clinical Investigation|October 16, 2020
Peripheral artery disease and clinical outcomes in patients with atrial fibrillation: A report from the FANTASIIA registryVicente Bertomeu-Gonzalez, José Moreno-Arribas, María Asunción Esteve-Pastor, et al.
Pageof 27

Showing results (181-190 of 266) with videos related to

Sort By:
Pageof 27
Revista Espanola De Cardiologia (English Ed.)|October 18, 2011
Differences in outcome of heart failure with preserved or depressed systolic function in patients older than 70 years who receive beta blockersManuel Anguita, Juan C Castillo, Martín Ruiz, et al.
Revista Espanola De Cardiologia (English Ed.)|September 22, 2016
Challenges in Oral Lipid-lowering Therapy: Position Document of the Spanish Society of CardiologyManuel Anguita Sánchez, Almudena Castro Conde, Alberto Cordero Fort, et al.
REC, Interventional Cardiology|May 29, 2025
Infectious endocarditis on percutaneous aortic valve prosthesis: comparison with surgical bioprosthesesLucas Barreiro, Álvaro Roldán, Nerea Aguayo, et al.
Journal of Geriatric Cardiology : JGC|August 26, 2024
Clinical profile and outcomes in very elderly patients with atrial fibrillation anticoagulated with rivaroxaban: data from the EMIR studyFrancisco Marín, Manuel Anguita Sánchez, Iñaki Lekuona, et al.
European Journal of Internal Medicine|April 19, 2020
Influence of sex on long-term prognosis in patients with atrial fibrillation treated with oral anticoagulants. Results from the prospective, nationwide FANTASIIA studyInmaculada Roldán Rabadán, María Asunción Esteve-Pastor, Manuel Anguita Sánchez, et al.
Journal of the American Heart Association|December 25, 2019
Association of Body Mass Index With Clinical Outcomes in Patients With Atrial Fibrillation: A Report From the FANTASIIA RegistryVicente Bertomeu-Gonzalez, José Moreno-Arribas, María Asunción Esteve-Pastor, et al.
Journal of Clinical Medicine|January 8, 2025
No Obesity Paradox for Health-Related Quality of Life in Patients with Heart Failure and Reduced Ejection Fraction: Insights from the VIDA Multicenter StudyPaula Cassadó-Valls, Cristina Enjuanes, Manuel Anguita, et al.
Revista Espanola De Cardiologia (English Ed.)|August 31, 2016
Classification and Quality Standards of Heart Failure Units: Scientific Consensus of the Spanish Society of CardiologyManuel Anguita Sánchez, José Luis Lambert Rodríguez, Ramón Bover Freire, et al.
Expert Opinion on Pharmacotherapy|August 4, 2022
A comparison of front-line oral anticoagulants for the treatment of non-valvular atrial fibrillation: effectiveness and safety of direct oral anticoagulants in the FANTASIIA registryMaría Asunción Esteve-Pastor, José Miguel Rivera-Caravaca, Martín Ruiz-Ortiz, et al.
European Journal of Clinical Investigation|October 16, 2020
Peripheral artery disease and clinical outcomes in patients with atrial fibrillation: A report from the FANTASIIA registryVicente Bertomeu-Gonzalez, José Moreno-Arribas, María Asunción Esteve-Pastor, et al.
Pageof 27